NASDAQ:ABP - Nasdaq - US0008471031 - Common Stock - Currency: USD
0.318
-0.01 (-3.93%)
The current stock price of ABP is 0.318 USD. In the past month the price decreased by -22.74%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 18.39 | 329.14B | ||
AMGN | AMGEN INC | 14.17 | 150.99B | ||
GILD | GILEAD SCIENCES INC | 13.33 | 128.61B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 1702.9 | 126.96B | ||
REGN | REGENERON PHARMACEUTICALS | 13.2 | 65.88B | ||
ARGX | ARGENX SE - ADR | 330.52 | 37.54B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.72B | ||
ONC | BEIGENE LTD-ADR | N/A | 26.39B | ||
BNTX | BIONTECH SE-ADR | N/A | 24.52B | ||
NTRA | NATERA INC | N/A | 20.79B | ||
BIIB | BIOGEN INC | 7.22 | 17.39B | ||
SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.31B |
Abpro Holdings, Inc. operates as a capital pool company. The company is headquartered in New York City, New York and currently employs 15 full-time employees. The company went IPO on 2022-01-14. The firm is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its DiversImmune and MultiMab antibody discovery and engineering platforms, it is engaged in developing a pipeline of antibodies, both independently and through collaborations with global pharmaceutical and research institutions. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting human epidermal growth factor receptor 2 (HER2), and cluster of differentiation 3 (CD3), T-cell co-receptor.
ABPRO HOLDINGS INC
6 St Johns Lane, Floor 5
New York City NEW YORK US
Employees: 15
Company Website: https://abpro.co/
Phone: 12488907200
The current stock price of ABP is 0.318 USD. The price decreased by -3.93% in the last trading session.
The exchange symbol of ABPRO HOLDINGS INC is ABP and it is listed on the Nasdaq exchange.
ABP stock is listed on the Nasdaq exchange.
5 analysts have analysed ABP and the average price target is 4.08 USD. This implies a price increase of 1183.02% is expected in the next year compared to the current price of 0.318. Check the ABPRO HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ABPRO HOLDINGS INC (ABP) has a market capitalization of 16.61M USD. This makes ABP a Nano Cap stock.
ABPRO HOLDINGS INC (ABP) currently has 15 employees.
ABPRO HOLDINGS INC (ABP) has a support level at 0.31 and a resistance level at 0.34. Check the full technical report for a detailed analysis of ABP support and resistance levels.
The Revenue of ABPRO HOLDINGS INC (ABP) is expected to decline by -100% in the next year. Check the estimates tab for more information on the ABP EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ABP does not pay a dividend.
ABPRO HOLDINGS INC (ABP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.28).
Over the last trailing twelve months ABP reported a non-GAAP Earnings per Share(EPS) of -0.28. The EPS decreased by -292.67% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -259.69% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 80% to ABP. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of 30.22% and a revenue growth -100% for ABP